Joy Wallenberg
About
In The Last Decade
Joy Wallenberg
8 papers receiving 600 citations
Peers
Comparison fields: 5 of 61
- Pathology and Forensic Medicine 479
- Neurology 168
- Rheumatology 153
- Oncology 105
- Psychiatry and Mental health 66
Countries citing papers authored by Joy Wallenberg
This map shows the geographic impact of Joy Wallenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joy Wallenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joy Wallenberg more than expected).
Fields of papers citing papers by Joy Wallenberg
This network shows the impact of papers produced by Joy Wallenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joy Wallenberg. The network helps show where Joy Wallenberg may publish in the future.
Co-authorship network of co-authors of Joy Wallenberg
This figure shows the co-authorship network connecting the top 25 collaborators of Joy Wallenberg. A scholar is included among the top collaborators of Joy Wallenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joy Wallenberg. Joy Wallenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 291 | |
| 2 | 141 | |
| 3 | 61 | |
| 4 | 92 | |
| 5 | 29 | |
| 6 | 2 | |
| 7 | Peak cerebrospinal fluid platinum levels in a patient with ependymoma: evaluation of two different methods of cisplatin administration. | 12 |
| 8 | Fatal congestive heart failure following mitoxantrone treatment in two children previously treated with doxorubicin and cisplatin. | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.